Advertisement

November 2006

Volume 68SupplementS1-336
28th Congress of the Société Internationale d´Urologie
12 November 2006 - 16 November 2006

Podium Sessions

    PD-01: Prostate Cancer 1

    • PD-01.01

      Even in low PSA ranges (0-2.5 ng/ml/cc) the PSA density of the transition zone is a very significant adjunct to serum PSA in differentiating prostate cancer from benign disease

      • V. Scattoni,
      • T. Ben Addi,
      • P. Hoffman,
      • ...
      • P. Rigatti,
      • F. Montorsi,
      • A.R. Zlotta
      Published in issue: November 2006
      p1
    • PD-01.02

      The PSA era is not over for detecting prostate cancer: correlations between PSA levels and transition zone volume in 1952 men with PSA levels < 10 ng / ml who underwent 10-14 biopsies

      • V. Scattoni,
      • T. Ben Addi,
      • C.C. Schulman,
      • P. Rigatti,
      • F. Montorsi,
      • A.R. Zlotta
      Published in issue: November 2006
      p1
    • PD-01.03

      Is adjuvant androgen deprivation therapy a treatment of curative intent?

      • N. Fleshner,
      • T.E. Keane,
      • C.A. Lawton,
      • ...
      • H. Payne,
      • S. Taneja,
      • T. Morris
      Published in issue: November 2006
      p1-2
    • PD-01.04

      Phase II dose finding study of ozarelix, an LHRH antagonist, in patients with inoperable prostate cancer

      • F.M.J. Debruyne,
      • K. Neykov,
      • V.D. Taskova,
      • ...
      • G. Lenaz,
      • M. Peukert,
      • J. Engel
      Published in issue: November 2006
      p2
    • PD-01.05

      Analysis of body temperature changes during hot flushes in men after bilateral orchidectomy (BO) for prostate cancer

      • N.A. Aziz,
      • C.F. Heyns
      Published in issue: November 2006
      p2
    • PD-01.06

      PSA / PAP ratio is a significant prognostic factor in patients with stage IV prostate cancer

      • T. Saito,
      • N. Hara,
      • Y. Kitamura,
      • S. Komatsubara
      Published in issue: November 2006
      p2-3
    • PD-01.07

      ATP combination therapy enhances the cytotoxic effect of mitoxantrone in hormone refractory prostate cancer

      • M. Shabbir,
      • C.S. Thompson,
      • R.J. Morgan,
      • G. Burnstock
      Published in issue: November 2006
      p3
    • PD-01.08

      Pragmatic recommendations and directions for future work based on a meta-analysis of 1653 patients treated with intermittent hormone therapy (IHT) for adenocarcinoma of the prostate

      • G. Shaw,
      • J. Cuzick,
      • L. Goldenberg,
      • ...
      • M. Scholz,
      • W. Albrecht,
      • T. Oliver
      Published in issue: November 2006
      p3
    • PD-01.09

      The relationship between tumor volume and the number of positive cores in men undergoing multisite extended biopsy: implication for expectant management

      • A. Ochiai,
      • P. Troncoso,
      • M. Chen,
      • R.J. Babaian
      Published in issue: November 2006
      p3-4
    • PD-01.10

      Erectile dysfunction in men treated with visually directed HIFU for clinically localized prostate cancer

      • R.O. Illing,
      • S. Dawkins,
      • C.W. Ogden,
      • M. Emberton
      Published in issue: November 2006
      p4

    PD-02: BPO / LUTS

    • PD-02.01

      The effects of one-year treatment with an isoflavone extract from red clover on prostate, liver, sexual function and quality of life in men

      • P. Engelhardt,
      • C. Riedl
      Published in issue: November 2006
      p4
    • PD-02.02

      The effects of alpha-blockers, finasteride and plant extracts on the need for surgical treatment among Slovakian men with benign prostatic hyperplasia: a cross-sectional study of ten years’ follow-up

      • J. Svihra,
      • Baska,
      • A. Szalayova,
      • ...
      • L. Poliak,
      • J. Luptak,
      • J. Kliment
      Published in issue: November 2006
      p4-5
    • PD-02.03

      A low vitamin D level is an independent risk factor for the development of benign prostatic hyperplasia

      • J. Hammarsten,
      • J.-E. Damber,
      • O. Johnell,
      • ...
      • U. Smith,
      • W. Waern,
      • D. Mellström
      Published in issue: November 2006
      p5
    • PD-02.04

      Myocardial injury during transurethral prostatectomy: identification, incidence, and risk factors

      • H. Ibrahim,
      • D. Brathwaite,
      • Z. Hussain,
      • ...
      • M.J. Hallworth,
      • P.W. Jones,
      • S.W.V. Coppinger
      Published in issue: November 2006
      p5-6
    • PD-02.05

      Effect of dutasteride on improvement of each IPSS item in patients with symptomatic benign prostatic hyperplasia

      • F. Desgrandchamps,
      • S. Droupy,
      • J. Irani,
      • C. Saussine,
      • A. Comenducci
      Published in issue: November 2006
      p6
    • PD-02.06

      Impact of baseline variables on the risk of BPH/LUTS progression: results of a 2-year placebo-controlled study with alfuzosin 10mg once daily

      • C. Roehrborn
      • ALTESS study group
      Published in issue: November 2006
      p6-7
    • PD-02.07

      Serum prostate-specific antigen is a predictor of the transition zone volume rather than total prostate volume in men with benign prostatic hyperplasia

      • A.R. Zlotta,
      • T. Ben Addi,
      • C.C. Schulman,
      • P. Rigatti,
      • V. Scattoni,
      • F. Montorsi
      Published in issue: November 2006
      p7
    • PD-02.08

      The efficacy and safety of tadalafil administered once a day for lower urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH)

      • C.G. Roehrborn,
      • K.T. McVary,
      • J.D. Kaminestsky,
      • ...
      • A. Sesler,
      • G.D. Sides,
      • B.S. Denes
      Published in issue: November 2006
      p7-8
    • PD-02.09

      Finasteride alone maintains stable urinary symptoms (ipss) in men with benign prostatic hyperplasia after 9 months of combination therapy using an alpha-blocker and finasteride

      • M. Elhilali,
      • C. Dupont,
      • C. Koch
      • PROACT study centers
      Published in issue: November 2006
      p8
    • PD-02.10

      Day surgery transurethral resection of prostate: our initial experience

      • W.J. Chua,
      • M.J.B. Tibung,
      • D. Consigliere
      Published in issue: November 2006
      p8
    • PD-02.11

      Cetrorelix pamoate, an LHRH antagonist, in the treatment of BPH: randomized, placebo-controlled multicenter study

      • F.M.J. Debruyne,
      • M. Tzvetkov,
      • Z. Medverec,
      • S. Altarac,
      • M. Peukert,
      • J. Engel
      Published in issue: November 2006
      p8-9

    PD-03: Female Urology

    • PD-03.01

      Peri-urethral Zuidex injection: a walk-in, walkout treatment for stress urinary incontinence

      • H.P. Marsh,
      • N. Dunne,
      • S.J. Foley
      Published in issue: November 2006
      p9
    • PD-03.02

      Tension-free vaginal tape and autologous rectus fascia pubovaginal sling for the treatment of stress urinary incontinence: a medium-term follow-up

      • F. Sharifi-Aghdas,
      • N. Mortazavi
      Published in issue: November 2006
      p9
    • PD-03.03

      Comparison of lower urinary tract symptoms (LUTS) reported in voiding diary and its agreement to urologist and nurse assessment

      • J. Gajewski,
      • J. Puthenparumpil,
      • S. Weerasinghe
      Published in issue: November 2006
      p9-10
    • PD-03.04

      Value of the I-PSS in women with bladder outlet obstruction following anti-incontinence surgery

      • T. Fourie
      Published in issue: November 2006
      p10
    • PD-03.05

      Social demographic and clinical characteristics of females having lower urinary tract symptoms (FLUTS) in northern Malaysia: preliminary results from the FLUTS cohort study

      • B.Y. Low,
      • M.L. Liong,
      • K.H. Yuen,
      • ...
      • W.S. Leong,
      • N. Karim,
      • P.Y. Cheah
      Published in issue: November 2006
      p10-11
    • PD-03.06

      The effects of duloxetine on urethral function and sphincter structure

      • S. Athanasiou,
      • C. Chaliha,
      • A. Digesu,
      • ...
      • A. Rodolakis,
      • S. Jeffery,
      • A. Antsaklis
      Published in issue: November 2006
      p11
    • PD-03.07

      Kiricuta’s omentoplasty in the treatment of vesico-vaginal fistulae

      • D.-S. Popescu,
      • A.D. Gavris,
      • C.C. Turcu
      Published in issue: November 2006
      p11
    • PD-03.08

      An implant for the surgical treatment of stress urinary incontinence: Remeex System (TRT)

      • J. Cabrera Pérez,
      • I. Bravo Fernández,
      • G. Pérez,
      • C. González Enguita
      Published in issue: November 2006
      p11-12
    • PD-03.09

      Long term outcome of laparoscopic promontofixation for vaginal prolapse

      • R. Sabbagh,
      • P.E. Bryckaert,
      • E. Mandron,
      • J. Piussan
      Published in issue: November 2006
      p12

    PD-04: Stones

    • PD-04.01

      Clinical evaluation of the Stonebreaker, a new pneumatic intracorporeal lithotripter

      • A. Rané,
      • P. Rao,
      • S.V. Kandaswamy,
      • R. Kumar,
      • N. Gupta
      Published in issue: November 2006
      p12-13
    • PD-04.02

      Novel deflecting stone basket improves calyceal access

      • M. Monga,
      • D. Weiland,
      • B.K. Canales,
      • J. Landman
      Published in issue: November 2006
      p13
    • PD-04.03

      Chronic dietary potassium depletion increases urinary oxalate excretion in rats

      • R.Z. Hossain,
      • C. Yachantha,
      • Y. Ogawa,
      • ...
      • M. Morozumi,
      • K. Sugaya,
      • P. Tosukhowong
      Published in issue: November 2006
      p13
    • PD-04.04

      Vitamin B6 deficiency causes hypocitraturia within one week in rats

      • Y. Ogawa,
      • R.Z. Hossain,
      • K. Yamakawa,
      • ...
      • Y. Oshiro,
      • A. Uchida,
      • K. Sugaya
      Published in issue: November 2006
      p13
    • PD-04.05

      Radial dilation of nephrostomy balloons: a comparative in vitro analysis

      • M. Monga,
      • K. Hendlin
      Published in issue: November 2006
      p13-14
    • PD-04.06

      Beneficial effect of lime powder intake on urinary oxidative status: a promising defence towards tubular injury

      • C. Yachantha,
      • T. Sasivongsbhakdi,
      • S. Chaisawasdi,
      • ...
      • Y. Ogawa,
      • K. Tangsanga,
      • P. Tosukhowong
      Published in issue: November 2006
      p14
    • PD-04.07

      Novel inhibitors of calcium oxalate crystallisation

      • S.E. Allen,
      • C.H. Fry,
      • S. Choong,
      • W.G. Robertson
      Published in issue: November 2006
      p14
    • PD-04.08

      Laparoscopic management of upper urinary tract stones: a report of 134 cases

      • N. Simforoosh,
      • A. Bassiri,
      • A. Danesh,
      • ...
      • F. Sharifi Aghdas,
      • A. Tabibi,
      • H. Abdi
      Published in issue: November 2006
      p15
    • PD-03.09

      Physical characteristics of next-generation ureteral access sheaths: buckling and kinking

      • K. Hendlin,
      • W.K. Durfee,
      • M. Monga
      Published in issue: November 2006
      p15
    • PD-04.10

      Virtual reality percutaneous nephrostomy simulator: stab in the dark or valuable tool?

      • J.R. Henderson,
      • K. Thomas,
      • P. Dasgupta,
      • J.M. Glass
      Published in issue: November 2006
      p15
    • PD-04.11

      In vitro testing of a novel ureteroscopic plug to control projectile stone fragments

      • D.M. Albala,
      • G. Kolb
      Published in issue: November 2006
      p15-16

    PD-05: Pediatric Urology

    • PD-05.01

      Protective effect of ADI on reperfusion injury following testicular torsion

      • C. Yoon,
      • D. Yoon,
      • M. Oh,
      • Y. Shim,
      • B. Min,
      • D. Yoon
      Published in issue: November 2006
      p16
    • PD-05.02

      Endoscopic management of vesicoureteral reflux with dextranomer/hyaluronic acid copolymer (Deflux) with 196 ureters in 125 patients

      • A.N. Bissada,
      • A.S. Safwat,
      • N.K. Bissada
      Published in issue: November 2006
      p16
    • PD-05.03

      Urodynamic risk factors against spontaneous resolution of primary vesico-ureteral reflux in male infants

      • Y. Igawa,
      • M. Ichino,
      • S. Seki,
      • Y. Iijima,
      • O. Ishizuka,
      • O. Nishizawa
      Published in issue: November 2006
      p16
    • PD-05.04

      Child, family and socio-economic- dependent risk factors on nocturnal enuresis

      • H. Basar,
      • M. Basar,
      • M. Saygun,
      • ...
      • A. Cakmak,
      • D. Tuglu,
      • E. Batislam
      Published in issue: November 2006
      p17
    • PD-05.05

      When should cryptorchid boys have surgery? A prospective randomized controlled study

      • C. Kollin,
      • U. Hesser,
      • M. Ritzén,
      • B. Karpe
      Published in issue: November 2006
      p17
    • PD-05.06

      Evaluation of relationship between adenotonsilar hypertrophy and enuresis in children

      • M. Mohamadzadeh Rezaei,
      • M. Aslzare
      Published in issue: November 2006
      p17
    • PD-05.07

      Outcome analysis of one-stage repair for severe hypospadias

      • L.H.P. Braga,
      • J.L. Pippi Salle,
      • A.J. Lorenzo,
      • D. Bagli,
      • A.E. Khoury
      Published in issue: November 2006
      p18
    • PD-05.08

      Surgical anatomy of epispadias and its impact on surgical treatment

      • M. Djordjevic,
      • S. Perovic,
      • V. Vukadinovic
      Published in issue: November 2006
      p18
    • PD-05.09

      Tubularized incised urethral plate versus tubularized intact urethral plate for hypospadias repair: a comparative study

      • A. Elbakry
      Published in issue: November 2006
      p18
Advertisement